↓ Skip to main content

Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study

Overview of attention for article published in Frontiers in oncology, April 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment—A Cardio-Oncology Study
Published in
Frontiers in oncology, April 2021
DOI 10.3389/fonc.2021.664741
Pubmed ID
Authors

Michał Wilk, Anna Waśko-Grabowska, Iwona Skoneczna, Sebastian Szmit

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 16%
Researcher 4 13%
Student > Bachelor 2 6%
Other 1 3%
Lecturer 1 3%
Other 4 13%
Unknown 14 45%
Readers by discipline Count As %
Medicine and Dentistry 9 29%
Neuroscience 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Sports and Recreations 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Other 2 6%
Unknown 15 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2021.
All research outputs
#5,329,253
of 25,477,125 outputs
Outputs from Frontiers in oncology
#1,861
of 22,568 outputs
Outputs of similar age
#126,469
of 454,121 outputs
Outputs of similar age from Frontiers in oncology
#125
of 1,123 outputs
Altmetric has tracked 25,477,125 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,568 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,121 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 1,123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.